Has Charles Lapp received payments from drug or device companies?

Yes. Drug and device makers reported $2,958 in general payments to Charles Lapp across 164 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Charles Lapp did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Charles Lapp come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Charles Lapp

Internal Medicine · Charlotte, NCNPI 1588778534

Payments from drug & device makers

$2,958in general payments, 2019–2025

Across 164 payments — averaging $18.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$416
Biohaven Pharmaceuticals, Inc.$374
Pfizer$286
Bausch Health US, LLC$254
Biohaven Pharmaceutical Holding Company Ltd.$252
Lilly USA, LLC$188
plus $1K from 24 others

What the payments were for

Food & beverage$2,958100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	24	$416
Biohaven Pharmaceuticals, Inc.	18	$374
Pfizer	15	$286
Bausch Health US, LLC	17	$254
Biohaven Pharmaceutical Holding Company Ltd.	13	$252
Lilly USA, LLC	8	$188
Biodelivery Sciences International, Inc.	7	$109
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	6	$102
Amgen	5	$94
Collegium Pharmaceutical, Inc.	5	$91
Eisai Inc.	6	$78
Arbor Pharmaceuticals, Inc.	5	$75
Forte Bio-pharma LLC	1	$71
Idorsia Pharmaceuticals US Inc	3	$61
Almatica Pharma LLC	3	$58
Scilex Pharmaceuticals Inc.	4	$57
Harmony Biosciences LLC	3	$56
Jazz Pharmaceuticals Inc.	3	$52
Takeda Pharmaceuticals U.S.A., Inc.	3	$44
Merck	2	$41
Teva Pharmaceuticals USA, Inc.	3	$38
Astellas Pharma US Inc	2	$30
Novartis	1	$20
Daiichi Sankyo Inc.	1	$19
Grifols USA, LLC	1	$18
Hikma Pharmaceuticals USA	1	$18
Optinose US, Inc.	1	$17
Avadel CNS Pharmaceuticals, LLC	1	$16
Acella Pharmaceuticals, LLC	1	$12
Shire North American Group Inc	1	$12

How this compares

$2,958 in reported general payments places this provider in the 80th percentile of 3,302 internal medicine providers in North Carolina.

See all internal medicine providers in North Carolina →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Clonazepam	60	$635
Gabapentin	31	$580
Fludrocortisone Acetate	15	$428
Carisoprodol	12	$381
Duloxetine Hcl	11	$360
Tizanidine Hcl	14	$242
Trazodone Hcl	25	$207
Bupropion Hcl SrBupropion Hcl	12	$201
Topiramate	12	$158
Lorazepam	11	$139
Sumatriptan Succinate	16	$122
Zolpidem Tartrate	12	$76
Alprazolam	13	$62

Paid to pharmacies, not to this prescriber.

Other internal medicine in Charlotte

Saad UsmaniCharlotte$16.2M
Christina KennellyCharlotte$15.4M
Lyndsay MolinariCharlotte$2.4M
Claud GriggCharlotte$1.5M
Maher AghaCharlotte$1M
Jonathan SchwartzCharlotte$824K
Marc JohnsonCharlotte$823K
Santosh GopalakrishnanCharlotte$598K
Maithili ChitnavisCharlotte$536K
Christopher FerreriCharlotte$434K

See the full list for North Carolina →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →